Sanofi

Clinical Study Results Medicines, including Rare Diseases

Important

Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country. In the event that the product is described as no longer a Sanofi product, reasons could include that the product was transferred to another company.

This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.

Filter by:

And

1248 result(s) found
Generic NameTrade NameCondition(s)Study CodeStudy NameAccess to Study / ProtocolAccess to Results
PLERIXAFOR
Mozobil
Non-Hodgkin's Lymphoma
ACT12781NANCT02221492Summary
PLERIXAFOR
Mozobil
Multiple Myeloma
ACT13710NANCT02221479Summary
PLERIXAFOR
Mozobil
Multiple Myeloma or Non-Hodgkin's Lyjmphoma
AMD3100-2104NANCT00322387Tabulated Results
PLERIXAFOR
Mozobil
Multiple Myeloma or Non-Hodgkin's Lyjmphoma
AMD3100-2105NANCT00322491Tabulated Results
PLERIXAFOR
Not marketed
Hodgkin's Disease
AMD3100-2106NANCT00396201Tabulated Results
PLERIXAFOR
Mozobil
Multiple Myeloma
AMD3100-2108NANCT00396383Tabulated Results
PLERIXAFOR
Mozobil
Multiple Myeloma or Non-Hodgkin's Lyjmphoma
AMD3100-2109NANCT00395967Tabulated Results
PLERIXAFOR
Not marketed
Renal Impairment
AMD31001101NANCT00445302Tabulated Results
PLERIXAFOR
Not marketed
Transplantation
AMD31002112NANCT00396331Tabulated Results
PLERIXAFOR
Mozobil
Non-Hodgkin's Lymphoma or Hodgkin's Disease
AMD31002113NANCT00444912Tabulated Results

References:

* These study results were previously posted on GenzymeClinicalResearch.com
** This link replaces the same summary that was previously posted